Abstract
At the end of 2015, the Tempo Magazine investigation team released a gratification case conducted by the pharmaceutical company Interbat against 2,125 doctors. The gratuities are suspected to be one of the reasons that influence doctors in prescribing drugs to patients. Funds used by pharmaceutical companies to serve doctors can reach 45 percent of drug prices. Therefore, patients must redeem the drug at a more expensive price. Moving from the results of these investigations, the authors are interested to examine criminal rules that can ensnare doctors who receive the gift from pharmaceutical companies. So far, the rule of law governing the prohibition of doctors receiving gifts from Pharmaceutical Companies has not had a deterrent effect. The existing arrangements are in the realm of ethics and administration. As a result, the cooperation of doctors and pharmaceutical companies in prescribing the drug continues and affects the patient's harm. Because in the practice of the physician profession is divided into two, namely private doctors and civil servants, then the formulation of the issues to be discussed in this paper is, First, how the imposition of legal sanctions for private doctors who receive the gift from Pharmaceutical Company Second, how the imposition of legal sanctions for civil servant doctors who receive the gift from Pharmaceutical Company To answer the problem, the author uses normative juridical research method. The results of his research are private doctors who receive the gift from pharmaceutical companies may be subject to Article 3 of Law Number 11 Year 1980 on the Crime of Bribery. As for doctors who have the status of Civil Servants subject to Article 12B of Law Number 31 Year 1999 junto Law Number 20 Year 2001 About Corruption Eradication (Anti-Corruption Law). As a suggestion at the end of the writing, the author wants that the formulation of Article 12B of the Anti-Corruption Law be expanded so that it is not limited to civil servants or state officials only. However, pending the improvement of the formulation of Article 12B, the authors recommend that law enforcement still play an active role by using Article 3 of the Anti-Bribery Law to ensnare doctors who receive the gift from ph armaceutical companies.
Highlights
Di penghujung tahun 2015, tim investigasi Majalah Tempo merilis adanya kasus gratifikasi yang dilakukan oleh perusahaan farmasi Interbat terhadap 2.125 dokter
the Tempo Magazine investigation team released a gratification case conducted by the pharmaceutical company Interbat against 2,125 doctors
Funds used by pharmaceutical companies to serve doctors can reach
Summary
Pelayanan kesehatan harus dilakukan oleh tenaga kesehatan dengan penuh tanggung jawab, memiliki etik dan moral yang tinggi, serta keahlian yang terus ditingkatkan mutunya melalui pendidikan dan pelatihan berkelanjutan agar penyelenggaraan upaya kesehatan memenuhi rasa keadilan dan perikemanusiaan serta sesuai dengan perkembangan ilmu pengetahuan dan teknologi kesehatan.[2]. Salah seorang dokter sekaligus guru besar farmakologi Universitas Gajah Mada, Iwan Dwiprahasto mengatakan bahwa alasan perusahaan farmasi memberikan hadiah dan komisi kepada dokter karena nilai bisnis obat ini sangat menjanjikan. Penulis ingin melakukan Tinjauan Hukum Dokter yang Berkolusi dengan Perusahaan Farmasi dalam Meresepkan Obat. Tujuannya agar praktek kolusi dalam pemberian pelayanan kesehatan tersebut tidak merugikan masyarakat sebagai pasien. Penjatuhan pidana atas dokter pegawai negeri tentu berbeda dengan dokter swasta yang menerima pemberian dari perusahaan farmasi. Maka penelitian ini ditujukan untuk mengetahui dan memahami pengaturan hukum yang tepat untuk menjatuhkan pidana terhadap dokter swasta dan dokter pegawai negeri yang menerima pemberian dari perusahaan farmasi
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
